Kanesmith11  יצר מאמר חדש
12 ב ·תרגם

3D Bioprinting Market Integration with Lab-on-Chip and Microfluidics Platforms | #organ-model bioprinting # preclinical tissue screening # patient-specific bioink # vascularized tissue chips # regulatory bioprinting standards # tumor organoid platform # toxicity testing alternatives # pharmaceutical bioprinting integration # preclinical pipeline innovation # personalized drug testing

3D Bioprinting Market Integration with Lab-on-Chip and Microfluidics Platforms

3D Bioprinting Market Integration with Lab-on-Chip and Microfluidics Platforms

The global 3D Bioprinting Market size is expected to be worth around USD 6.9 Billion by 2032 from USD 1.6 billion in 2022, growing at a CAGR of 16.1% during the forecast period from 2022 to 2032.